Search by Drug Name or NDC
NDC 70710-1302-07 Mesalamine 1000 mg/1 Details
Mesalamine 1000 mg/1
Mesalamine is a RECTAL SUPPOSITORY in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Zydus Pharmaceuticals USA Inc.. The primary component is MESALAMINE.
MedlinePlus Drug Summary
Rectal mesalamine is used to treat ulcerative colitis (a condition which causes swelling and sores in the lining of the colon [large intestine] and rectum), proctitis (swelling in the rectum), and proctosigmoiditis (swelling in the rectum and sigmoid colon [last section of the colon]). Rectal mesalamine is in a class of medications called anti-inflammatory agents. It works by stopping the body from producing a certain substance that may cause inflammation.
Related Packages: 70710-1302-07Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Mesalamine Rectal
Product Information
NDC | 70710-1302 |
---|---|
Product ID | 70710-1302_c4a4a31c-618f-42e7-ba11-4bf5939dff5b |
Associated GPIs | 52500030005240 |
GCN Sequence Number | 021776 |
GCN Sequence Number Description | mesalamine SUPP.RECT 1000 MG RECTAL |
HIC3 | Q3E |
HIC3 Description | CHRONIC INFLAM. COLON DX, 5-A-SALICYLAT,RECTAL TX |
GCN | 48490 |
HICL Sequence Number | 001848 |
HICL Sequence Number Description | MESALAMINE |
Brand/Generic | Generic |
Proprietary Name | Mesalamine |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Mesalamine |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | SUPPOSITORY |
Route | RECTAL |
Active Ingredient Strength | 1000 |
Active Ingredient Units | mg/1 |
Substance Name | MESALAMINE |
Labeler Name | Zydus Pharmaceuticals USA Inc. |
Pharmaceutical Class | Aminosalicylate [EPC], Aminosalicylic Acids [CS] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA208953 |
Listing Certified Through | 2024-12-31 |
Package
NDC 70710-1302-07 (70710130207)
NDC Package Code | 70710-1302-7 |
---|---|
Billing NDC | 70710130207 |
Package | 5 BLISTER PACK in 1 POUCH (70710-1302-7) / 6 SUPPOSITORY in 1 BLISTER PACK (70710-1302-6) |
Marketing Start Date | 2020-02-14 |
NDC Exclude Flag | N |
Pricing Information | |
Price Per Unit | 2.22806 |
Pricing Unit | EA |
Effective Date | 2024-02-21 |
NDC Description | MESALAMINE 1,000 MG SUPP |
Pharmacy Type Indicator | C/I |
OTC | N |
Explanation Code | 1 |
Classification for Rate Setting | G |
As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis